NO20000310L - Farmasøytiske sammensetninger som inneholder vitamin D og kalsium, deres fremstilling og terapeutisk anvendelse - Google Patents

Farmasøytiske sammensetninger som inneholder vitamin D og kalsium, deres fremstilling og terapeutisk anvendelse

Info

Publication number
NO20000310L
NO20000310L NO20000310A NO20000310A NO20000310L NO 20000310 L NO20000310 L NO 20000310L NO 20000310 A NO20000310 A NO 20000310A NO 20000310 A NO20000310 A NO 20000310A NO 20000310 L NO20000310 L NO 20000310L
Authority
NO
Norway
Prior art keywords
calcium
preparation
containing vitamin
pharmaceutical compositions
compositions containing
Prior art date
Application number
NO20000310A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000310D0 (no
Inventor
Maurizio Valleri
Alessandro Tosetti
Original Assignee
Menarini International Operati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini International Operati filed Critical Menarini International Operati
Publication of NO20000310D0 publication Critical patent/NO20000310D0/no
Publication of NO20000310L publication Critical patent/NO20000310L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20000310A 1997-07-30 2000-01-21 Farmasøytiske sammensetninger som inneholder vitamin D og kalsium, deres fremstilling og terapeutisk anvendelse NO20000310L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97FI000184A ITFI970184A1 (it) 1997-07-30 1997-07-30 Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
PCT/EP1998/004567 WO1999006051A1 (en) 1997-07-30 1998-07-21 Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use

Publications (2)

Publication Number Publication Date
NO20000310D0 NO20000310D0 (no) 2000-01-21
NO20000310L true NO20000310L (no) 2000-01-21

Family

ID=11352223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000310A NO20000310L (no) 1997-07-30 2000-01-21 Farmasøytiske sammensetninger som inneholder vitamin D og kalsium, deres fremstilling og terapeutisk anvendelse

Country Status (28)

Country Link
US (1) US7067154B1 (is)
EP (1) EP0999843B1 (is)
JP (1) JP4497496B2 (is)
KR (1) KR100573421B1 (is)
AT (1) ATE271387T1 (is)
AU (1) AU8978198A (is)
BG (1) BG65044B1 (is)
BR (1) BR9810832B1 (is)
CA (1) CA2299420C (is)
CZ (1) CZ297670B6 (is)
DE (1) DE69825164D1 (is)
EA (1) EA002492B1 (is)
EE (1) EE04046B1 (is)
ES (1) ES2223135T3 (is)
HU (1) HU226112B1 (is)
ID (1) ID23504A (is)
IL (1) IL134268A0 (is)
IS (1) IS5359A (is)
IT (1) ITFI970184A1 (is)
NO (1) NO20000310L (is)
PL (1) PL189295B1 (is)
PT (1) PT999843E (is)
RS (1) RS49703B (is)
SI (1) SI0999843T1 (is)
SK (1) SK284873B6 (is)
TR (1) TR200000261T2 (is)
UA (1) UA61968C2 (is)
WO (1) WO1999006051A1 (is)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040071789A1 (en) * 2002-02-14 2004-04-15 Baron John A Calcium supplementation to reduce prostate cancer risk
ES2192136B1 (es) * 2002-01-04 2005-03-16 Italfarmaco, S.A. Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.
ITFI20030194A1 (it) * 2003-07-17 2005-01-18 Menarini Int Operations Lu Sa Composizione farmaceutiche effervescenti contenenti
EA011746B1 (ru) 2004-05-24 2009-06-30 Никомед Фарма Ас Агломерация кальцийсодержащего соединения прессованием на валках
UA86816C2 (uk) 2004-06-01 2009-05-25 Нікомед Фарма Ас Таблетка для жування, смоктання та ковтання, яка містить кальційвмісну сполуку як активну речовину і цукровий спирт
US8846088B2 (en) 2005-02-03 2014-09-30 Takeda Nycomed As Melt granulation of a composition containing a calcium-containing compound
AU2006211023B2 (en) 2005-02-03 2012-05-24 Takeda Nycomed As Fast wet-massing method for the preparation of calcium-containing compositions
CA2624897C (en) * 2005-10-12 2017-02-14 Proventiv Therapeutics, Llc Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
UA92052C2 (ru) * 2005-12-07 2010-09-27 Нікомед Фарма Ас Предварительно уплотненные кальциесодержащие композиции
MXPA05014091A (es) * 2005-12-20 2007-06-20 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden derivados de esteroides sinteticos, minerales y el metabolito activo de la vitamina d, 1,25(oh)2d3 (calcitriol) para la prevencion y tratamiento de la osteoporosis y el control de los sintomas de la menopaus
CA2835910C (en) * 2007-04-25 2016-06-28 Warner Chilcott Company, Llc Improved vitamin d content uniformity in pharmaceutical dosage forms
PT2358374E (pt) 2008-11-17 2013-12-09 Takeda Nycomed As Estabilidade de dissolução melhorada de comprimidos de carbonato de cálcio
TR200900878A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
TR200900880A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik bileşimler.
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
US20120015913A1 (en) 2010-07-15 2012-01-19 Delansorne Remi Formulations of 14-EPI-Analogues of Vitamin D
JP6554034B2 (ja) * 2013-08-09 2019-07-31 日東薬品工業株式会社 カルシウム剤
CN105166935B (zh) * 2015-09-01 2018-08-31 张伟 一种含有维生素d3的液体制剂及其制备方法
FI3787596T3 (fi) 2018-05-02 2025-09-29 Ferring Bv Parannettuja farmaseuttisia formulaatioita
KR102211287B1 (ko) * 2018-12-21 2021-02-03 (주)휴온스 비타민 d 또는 이의 유도체를 포함하는 안정성이 개선된 액상 제제
JP2024512417A (ja) * 2021-03-12 2024-03-19 ニコベンチャーズ トレーディング リミテッド 自己乳化系を含む経口製品
WO2025079114A1 (en) * 2023-10-13 2025-04-17 Vytals Wellbeing India Pvt. Ltd. A self-nano emulsifying drug formulation for cholecalciferol

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073271A1 (en) * 1969-12-11 1971-10-01 Boivin Jean Calcium salt - vitamin d2 compn - for treatment of decalcification of
ZA813205B (en) * 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
DK8603837A (is) * 1985-08-13 1987-02-14
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
DE69124223T2 (de) * 1990-02-05 1997-04-30 Lifescience Corp Vitamine und mineralien enthaltende nahrungszusätze
DE69122099T2 (de) * 1990-05-16 1997-04-17 Margaret Hanausek Zusammensetzung und verfahren zur prävention und behandlung von hypercholesterinämie und zellproliferationsstorungen
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
IL103224A (en) * 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
FR2724844B1 (fr) * 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
FR2760639B1 (fr) * 1997-03-14 2000-09-22 Innothera Lab Sa Association therapeutique mineralo-vitaminique sous forme de preparation unitaire liquide buvable

Also Published As

Publication number Publication date
PL338237A1 (en) 2000-10-09
EP0999843A1 (en) 2000-05-17
PL189295B1 (pl) 2005-07-29
NO20000310D0 (no) 2000-01-21
US7067154B1 (en) 2006-06-27
HUP0100539A2 (hu) 2001-08-28
ID23504A (id) 2000-04-27
ES2223135T3 (es) 2005-02-16
BR9810832A (pt) 2000-07-25
JP4497496B2 (ja) 2010-07-07
EE04046B1 (et) 2003-06-16
IL134268A0 (en) 2001-04-30
TR200000261T2 (tr) 2000-09-21
EE200000054A (et) 2000-10-16
HK1027751A1 (en) 2001-01-23
EP0999843B1 (en) 2004-07-21
CA2299420A1 (en) 1999-02-11
CA2299420C (en) 2009-04-21
IS5359A (is) 2000-01-24
BG65044B1 (bg) 2007-01-31
HU226112B1 (en) 2008-04-28
BG104057A (en) 2000-07-31
ATE271387T1 (de) 2004-08-15
SK802000A3 (en) 2000-07-11
BR9810832B1 (pt) 2010-11-16
CZ2000199A3 (cs) 2000-05-17
KR20010022319A (ko) 2001-03-15
JP2001511453A (ja) 2001-08-14
WO1999006051A1 (en) 1999-02-11
RS49703B (sr) 2007-12-31
EA200000181A1 (ru) 2000-10-30
ITFI970184A1 (it) 1999-01-30
YU3700A (sh) 2002-11-15
DE69825164D1 (de) 2004-08-26
CZ297670B6 (cs) 2007-02-28
KR100573421B1 (ko) 2006-04-26
SI0999843T1 (en) 2005-02-28
UA61968C2 (en) 2003-12-15
EA002492B1 (ru) 2002-06-27
SK284873B6 (sk) 2006-01-05
AU8978198A (en) 1999-02-22
PT999843E (pt) 2004-11-30

Similar Documents

Publication Publication Date Title
NO20000310D0 (no) Farmasoeytiske sammensetninger som inneholder vitamin D og kalsium, deres fremstilling og terapeutisk anvendelse
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
DZ3165A1 (fr) Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie.
BR0100046A (pt) Copolìmeros reticulados solúveis em água ou intumescìveis em água
HUP9802448A2 (hu) Vérlemezke-aggregáció inhibitorvegyületei, ezek előállítása és alkalmazása és gyógyászati készítmények
FI973039A0 (fi) Uusia farnesyylitransferaasin inhibiittoreita, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
FI973279A7 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
FI962154A0 (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
ZA9711734B (en) Novel farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments.
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
SE9802937D0 (sv) Novel compounds
IL98917A0 (en) Piperidyl ethers and thioethers and their use as inhibitors of cholesterol biosynthesis
TR199701121T1 (xx) Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.
NO992998L (no) Nye analoger av camptotecin, anvendelse som medikamenter og farmasöytiske blandinger som inneholder disse
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
NO973401L (no) Kortikosteroidinneholdende sammensetninger og fremstilling derav
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
AU2811400A (en) Stable formulation containing fumagillin
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
ZA9811787B (en) Novel farnesyl transferase inhibitors, their preparation, pharmaceutical compositions which contain them and their use for the preparation of medicaments.
HUP9800277A3 (en) N-(1,2,3,4-tetrahydro-naphthyl- and -quinolyl)sulfonamide derivatives, their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing them
AU8430791A (en) Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them
BR9806851A (pt) ComposiçÊes farmaceuticas e alimenticias que contêm bactérias de gênero acetobacter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application